| Style | Citing Format |
|---|---|
| MLA | Alnofli H K D, et al.. "Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives." ChemistrySelect, vol. 11, no. 25, 2026, pp. -. |
| APA | Alnofli H K D, Khalil Moghaddam S, Iraji A, Jafary H, Mohammadi Khanaposhtani M, Eftekharian F, Mojtabavi S, Mahdavi M (2026). Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives. ChemistrySelect, 11(25), -. |
| Chicago | Alnofli H K D, Khalil Moghaddam S, Iraji A, Jafary H, Mohammadi Khanaposhtani M, Eftekharian F, Mojtabavi S, Mahdavi M. "Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives." ChemistrySelect 11, no. 25 (2026): -. |
| Harvard | Alnofli H K D et al. (2026) 'Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives', ChemistrySelect, 11(25), pp. -. |
| Vancouver | Alnofli H K D, Khalil Moghaddam S, Iraji A, Jafary H, Mohammadi Khanaposhtani M, Eftekharian F, et al.. Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives. ChemistrySelect. 2026;11(25):-. |
| BibTex | @article{ author = {Alnofli H K D and Khalil Moghaddam S and Iraji A and Jafary H and Mohammadi Khanaposhtani M and Eftekharian F and Mojtabavi S and Mahdavi M}, title = {Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives}, journal = {ChemistrySelect}, volume = {11}, number = {25}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Alnofli H K D AU - Khalil Moghaddam S AU - Iraji A AU - Jafary H AU - Mohammadi Khanaposhtani M AU - Eftekharian F AU - Mojtabavi S AU - Mahdavi M TI - Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives JO - ChemistrySelect VL - 11 IS - 25 SP - EP - PY - 2026 ER - |